Direct oral to parenteral anticoagulant transitions: Role of factor Xa inhibitor-specific anti-Xa concentrations.
Corey V DinunnoChelsea N LopezLuma SuccarDuc T NguyenEdward A GravissEric SalazarKevin R DonahuePublished in: Pharmacotherapy (2022)
This analysis suggests using FXaI anti-Xa concentrations to guide the transition from oral to parenteral anticoagulants may be beneficial in reducing major bleeds in select patient populations.